Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
As per the Thursday release, Endo will be folded into Mallinckrodt, which will then continue as the holding entity for the combined companies. Post-merger, the company will be listed on the New York Stock Exchange and is projected to generate around $3.6 billion in revenue this year.
After 31 years as a publicly-traded Massachusetts company, Aspen Technology has ceased to exist as an independent firm.
The Federal Deposit Insurance Corporation's board of directors approved a proposal Monday to roll back a Biden-era policy ...
Zacks Investment Research on MSN18h
Amcor-Berry Merger Gets U.S Antitrust Clearance, Set to Close Mid-2025Amcor plc AMCR announced that its previously announced merger deal with Berry Global Group, Inc. BERY has cleared another significant step with the expiration of the waiting period under the ...
There is nothing inherently wrong with the merger of two companies. Many on the left have adopted the view that mergers and ...
The University of Findlay, the larger and financially stronger of the two private, religiously affiliated institutions in northwest Ohio, was the one to call off the merger. Its Board of Trustees ...
Law firm tie-ups are the high-stakes courtship of the legal world—part strategy, part synergy, and a substantial dose of risk ...
The Federal Deposit Insurance Corporation is planning to propose rolling back a Biden-era policy that ramped up the scrutiny ...
Chief Executive Makoto Uchida is stepping down, with Chief Planning Officer Ivan Espinosa taking the helm of the Japanese ...
New Jersey City University has agreed to pursue a merger with nearby Kean University, a move encouraged by state officials to help stabilize NJCU after financial struggles in recent years. On ...
facility. 8/21/2023 TJC LP Delrin acetal business of DuPont Private equity firm TJC LP of New York acquired DuPont Co.'s 80 percent ownership of the Delrin acetal homopolymer (H-POM) business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback